168澳洲幸运5官网开奖 澳洲幸运5官方开奖结果体彩网 澳洲幸运5走势图 澳洲幸运五开奖记录中国体彩结果&
Touching Lives

About Sun Pharma

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

COVID-19 Response

We are committed to ensure uninterrupted supply of medicines to support the Covid-19 pandemic response

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

澳洲幸运5历史记录官网 澳洲5开奖官方网站 澳洲幸运5开奖官方平台

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue

Top
友情链接: 开奖网站 澳洲幸运5 澳洲幸运10开奖历史记录 澳洲幸运10开奖记录体彩 澳洲幸运8官方开奖历史 2022幸运飞艇官方开机历史记录 澳洲幸运10开官网 2022幸运飞艇官方开机历史记录 2022飞艇168开奖网 澳洲幸运5官方开奖结果体彩网 2022澳洲幸运5开奖历史结果 2022澳洲幸运5官方开奖直播结果视频 澳洲幸运10开奖结果历史开奖记录 澳洲幸运10官方开奖 2022澳洲幸运8历史记录 看飞艇168开奖历史官网 澳洲幸运10开奖结果历史开奖记录 幸运飞行艇官方开奖结果 168极速赛车全国最快开奖网 澳洲幸运8官方网站 澳洲幸运10开奖结果官方手机版